別 名
HVR 1; HVR1; PACAP R 2; PACAP type II receptor;
PACAP-R-2; PACAP-R2; Pituitary adenylate cyclase activating polypeptide
receptor type II; Pituitary adenylate cyclase activating polypeptide type II receptor;
Pituitary adenylate cyclase-activating polypeptide type II receptor; RCD1; RDC
1; RDC1; V1RG; VAPC 1; VAPC1; Vasoactive intestinal peptide receptor 1;
Vasoactive intestinal polypeptide receptor 1; Vasoactive intestinal polypeptide
receptor 1 precursor; VIP R 1; VIP receptor type I; VIP-R-1; VIPR 1; VIPR;
VIPR1; VIPR1_HUMAN; VIRG; VPAC 1; VPAC1; VPCAP1R; FLJ41949.
交叉反應(yīng)；Human, Mouse, Rat, (predicted: Pig, Cow, Rabbit, )
產(chǎn)品應(yīng)用；WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)）
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
免 疫 原；KLH conjugated synthetic
peptide derived from human VIP Receptor 1: 351-457/457 <Cytoplasmic>
亞 型；IgG
純化方法；affinity purified by Protein A
保存條件；Shipped at 4℃. Store at -20 °C for one year. Avoid
repeated freeze/thaw cycles.
注意事項；This product as supplied is
intended for research use only, not for use in human, therapeutic or diagnostic
applications.
血管活性腸肽受體-1抗體產(chǎn)品介紹：
|
Subcellular
Location:
Cytoplasm.
Nucleus.
|